chevrons

Back to Previous Page

Company Quarterly Earnings Update – TNH VN – 2021 9M

Summary of the 2021 9M results of Thai Nguyen International General Hospital JSC (TNH VN)

9M/2021 results: Highlights

  • Net revenue grew by 31.7% y/y to VND308bn thanks to (1) the total number of hospital visits reaching 247,407 (+33.0% y/y) including outpatients (222,868 visits, +36.0% y/y) and inpatients (24,539 visits, +18.0% y/y), (2) a 15.1% y/y rise in the average service fees since February 2021.
  • The gross margin increased to 52.4% from 46.1% in 9M/2020 owing to (1) a 15.1% increase in the average service fees, (2) a higher proportion of COVID testing services (quick test and PCR test) which have low CAPEX investment and higher profitability. As a result of robust sales growth and greater gross margin, operating profit increased by 46.8% y/y. However, interest expenses soared by 84.1% y/y due to a new loan for Thai Nguyen International Hospital’s expansion and additional working capital, resulting in a lower net profit growth of 36.8% y/y to reach VND110bn, with a net margin of 35.6% (+13bps y/y).
  • Financial health: 1% of total assets are cash and deposits. Leveraging was moderate with D/E and D/A ratios of 0.6x and 0.4x, respectively.
  • EGM updates: 25% of the 2020 stock dividend of will be executed from December 2021 to January 2022. Following that, in Q1/2022, current shareholders will have a 2:1 right to purchase new shares at VND16,000/share.

Outlook 2021-2022

  • For 2021: we maintain our forecast that net revenue and net profit will increase strongly by 45.0% y/y and 44.2% y/y to VND487bn and VND158bn respectively thanks to (1) a 11.7% growth in the total number of patients, (2) a 15.1% rise in the average service fees, (3) achieving economies of scale with Thai Nguyen International Hospital (TIGH) and Yen Binh General Hospital (YBGH).
  • For 2022: TNH will finish the TIGH’s 50-bed expansion in H1/2022, YBGH’s 150-bed expansion, and a new Maternity Hospital in Q4/2022. Overall, we project total consolidated net revenue to rise by 19.5% y/y to VND582bn, and a net profit of VND183bn (+15.5% y/y).

Company ratings and target prices are accessible for clients only.

If you are interested in getting full access to our paid Primary Research Materials feel free to get in touch with us at your convenience.

Our team is actively covering 50 companies in the listed Vietnamese equity space for our clients.


Featured image credit: cafef.vn

Related News & Insights
Find out more navigation_button
news

Summary of H1 2025 results and outlook of VPBank (VPB VN) Net income surged 22.8% y/y, fueled by accelerated credit expansion and continued sharp enhancement in asset quality. Total credit grew 30.3% y/y, driven by strong demand across diversified corporate sectors, as well as various retail segments including consumption, mortgages, and margin lending. Net interest […]

Read Newsarrow
news

Summary of Q2 2025 results and outlook of Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD VN) Net revenue rose 12.1% y/y to VND916 billion. By product category, the three strategic segments—Antibiotics (+14.8% y/y), Oncology (+13.8% y/y), and Dialysis solutions (+30.9% y/y)—together accounted for 63.5% of total sales. By distribution channel, the hospital segment, which […]

Read Newsarrow
news

Summary of Q2 2025 results and outlook of Binh Minh Plastics JSC (BMP VN) Net revenue reached VND2,691bn (+24.8% y/y), driven by a 25.5% y/y increase in sales volume. Growth was supported by an early recovery in real estate construction and the front-loaded timing of promotional campaigns (held in Q1 and end-Q2 vs. Q3 in […]

Read Newsarrow
Find out more navigation_button